Welcome to the Emapta COVID-19 Vaccine Hub.
Find the latest information on the Vaccination Program here.

Your health and safety are our top priority -  this is why we and our client partners are procuring the Moderna COVID-19 vaccine for our teams.  Together, this is our best shot to defeating the pandemic and keeping everyone around us safe.
 
This page will be updated regularly as soon as more information becomes available. Bookmark this page for the latest updates. 

Is the vaccination mandatory?

No, the vaccination against Covid-19 is not required regardless of your current work arrangement. Getting vaccinated is highly encouraged to ensure your safety and to help keep our community healthy.

Who will pay for the vaccine?

Emapta and client partners will shoulder the cost for its employees. Employees will not be required to pay for the vaccine.

How many vaccines did Emapta buy?

We have been able to place an order for 7,000 vaccine doses in the first order. Each person is to receive 2 doses, so we are confident to be able to offer a vaccine to all our employees. 

At this moment, we cannot confirm that dependents will be included in the first order. An extension to dependents/family members will be subject to delivery quantities allotted to Emapta, the acceptance rate among our employees and the possibility of additional vaccine orders in the future. 

Can our dependents be included?

Can additional orders be placed in the future?

Should Emapta be given the opportunity to place another order in the future, this will certainly be considered and will be shared with our staff and client partners.

Why did you choose Moderna?

Evidence from clinical trials show that the Moderna vaccine appeared to have high effectiveness 
(94.1% efficacy) among people of diverse age, sex, race, and ethnicity categories and among persons with underlying health conditions. It has also been approved for Emergency Use Authorisation (EUA) 
by the U.S. Food and Drug Administration, making Moderna a legitimate and highly trustworthy choice for a COVID-19 vaccine brand.

I want to know more about the Moderna vaccine

We understand that there are many questions about the Moderna vaccine. In the coming weeks, we will be sharing more information about the Moderna Vaccine, its effectiveness and safety features. In the meantime, you may want to read the World Health Organisations’ Overview of the Moderna Vaccine.

What’s the timeline for vaccine rollout and administration?

As of March 23, 2021, our orders have been confirmed and are on track for delivery from Q2 to Q4 this year, with the first batch expected to arrive in June. The exact delivery quantities and timelines are yet to be communicated to us by the logistics partner. Once this is received, we will provide an update on the expected rollout schedule and timeline.

Following government regulations, actual vaccination will be conducted in officially accredited facilities. This means Emapta offices will not be utilized to administer the vaccine.

Where will the vaccination take place?

Where can I get registered?

Once the delivery rollout schedule is confirmed, we will start a formal registration process for all Emapta employees. Every employee will be offered a vaccine and may choose to accept or deny the offer.

The Emapta COVID-19 Vaccine Hub will be updated as soon as more information becomes available. Bookmark this page to get the latest updates about our vaccine rollout.

Where can I get the latest information?

Emapta COVID-19 Vaccine Hub

Welcome to the Emapta
COVID-19 Vaccine Hub. Find the latest information on the Vaccination Program here.

Your health and safety are our top priority -  this is why we and our client partners are procuring the Moderna COVID-19 vaccine for our teams.  Together, this is our best shot to defeating the pandemic and keeping everyone around us safe.
 
This page will be updated regularly as soon as more information becomes available. Bookmark this page for the latest updates.  

Emapta COVID-19 Vaccine Hub

Is the vaccination mandatory?

No, the vaccination against Covid-19 is not required regardless of your current work arrangement. Getting vaccinated is highly encouraged to ensure your safety and to help keep our community healthy.

Who will pay for the vaccine? 

Emapta and client partners will shoulder the cost for its employees. Employees will not be required to pay for the vaccine. 

We have been able to place an order for 7,000 vaccine doses in the first order. Each person is to receive 2 doses, so we are confident to be able to offer a vaccine to all our employees. 

How many vaccines did Emapta buy? 

Can our dependents be included? 

At this moment, we cannot confirm that dependents will be included in the first order. An extension to dependents/family members will be subject to delivery quantities allotted to Emapta, the acceptance rate among our employees and the possibility of additional vaccine orders in the future.

Can additional orders be placed in the future? 

Should Emapta be given the opportunity to place another order in the future, this will certainly be considered and will be shared with our staff and client partners. 

Why did you choose Moderna?

Evidence from clinical trials show that the Moderna vaccine appeared to have high effectiveness 
(94.1% efficacy) among people of diverse age, sex, race, and ethnicity categories and among persons with underlying health conditions. It has also been approved for
Emergency Use Authorisation (EUA) 
by the U.S. Food and Drug Administration, making Moderna a legitimate and highly trustworthy choice for a COVID-19 vaccine brand.

I want to know more about Moderna Vaccine 

We understand that there are many questions about the Moderna vaccine. In the coming weeks, we will be sharing more information about the Moderna Vaccine, its effectiveness and safety features. In the meantime, you may want to read the World Health Organisations’ Overview of the Moderna Vaccine.

What’s the timeline for vaccine rollout and administration? 

As of March 23, 2021, our orders have been confirmed and are on track for delivery from Q2 to Q4 this year, with the first batch expected to arrive in June. The exact delivery quantities and timelines are yet to be communicated to us by the logistics partner. Once this is received, we will provide an update on the expected rollout schedule and timeline. 

Where will the vaccination take place? 

Following government regulations, actual vaccination will be conducted in officially accredited facilities. This means Emapta offices will not be utilized to administer the vaccine. 

Where can I get registered?

Once the delivery rollout schedule is confirmed, we will start a formal registration process for all Emapta employees. Every employee will be offered a vaccine and may chose to accept or deny the offer.

Where can I get the latest information?

The Emapta COVID-19 Vaccine Hub will be updated as soon as more information becomes available. Bookmark this page to get the latest updates about our vaccine rollout.

Name:
mRNA-1273
 
Manufacturer: 
ModernaTX, Inc. 

Official website: 
https://www.modernacovid19global.com/ 

Type of vaccine: 
mRNA 

Ingredients: 
messenger ribonucleic acid (mRNA), lipids (SM-102, polyethylene glycol [PEG] 2000 dimyristoyl glycerol [DMG], cholesterol, and 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC]), tromethamine, tromethamine hydrochloride, acetic acid, sodium acetate trihydrate, and sucrose. 

Allergen information: 
The vaccine is free from eggs, latex, and preservatives.

Administration: 
Intramuscular (IM) injection in the deltoid muscle (upper arm).

Schedule:
2-dose series separated by 28 days

Clinical Trial Results: 
The Moderna vaccine was 94.1% effective at preventing laboratory confirmed COVID-19 illness

FDA status: 
The US Food and Drug Administration (FDA) has approved the Emergency Use Authorisation
(EUA) of the Moderna vaccine to prevent COVID-19 in individuals 18 years of age and older. 

Name:
mRNA-1273
 
Manufacturer: 
ModernaTX, Inc. 

Official website: 
https://www.modernacovid19
global.com/ 

Type of vaccine: 
mRNA 

Ingredients: 
messenger ribonucleic acid (mRNA), lipids (SM-102, polyethylene glycol [PEG] 2000 dimyristoyl glycerol [DMG], cholesterol, and 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC]), tromethamine, tromethamine hydrochloride, acetic acid, sodium acetate trihydrate, and sucrose.

Allergen information: 
The vaccine is free from eggs, latex, and preservatives.

Administration: 
Intramuscular (IM) injection 
in the deltoid muscle 
(upper arm).

Schedule:
2-dose series separated 
by 28 days

Clinical Trial Results: 
The Moderna vaccine was 94.1% effective at preventing laboratory confirmed COVID-19 illness

FDA status: 
The US Food and Drug Administration (FDA) has approved the Emergency Use Authorisation (EUA) of the Moderna vaccine to prevent COVID-19 in individuals 18 years of age and older.  

1

2

3

4

5

What are the benefits of the Moderna COVID-19 vaccine?

In an ongoing clinical trial, the Moderna COVID-19 vaccine is proven to prevent COVID-19 following 2 doses given 1 month apart. The duration of protection against COVID-19 is currently unknown.

Does the vaccine work against new variants?

Based on the latest evidence collected by WHO, the new variants of SARS-CoV-2, including the B.1.1.7 (UK variant) and the 501Y.V2 (South African variant), do not alter the effectiveness of the Moderna mRNA vaccine.

Will the vaccine give me COVID-19?

No. The Moderna COVID-19 vaccine does not contain SARS-CoV-2 and cannot give you COVID-19.

Will the vaccine affect or change my DNA?

No. The Moderna COVID-19 vaccine does not affect or interact with a person’s DNA in any way.

How does the vaccine work?

The Moderna COVID-19 vaccine is an encapsulated mRNA vaccine. This type of vaccine gives instructions to our cells for the creation of a harmless “spike protein” that will develop the body’s immune response against COVID-19.

How is the Moderna vaccine given?

Only authorised healthcare professionals will administer the vaccine in two separate doses.

They will give the vaccine as an injection into the upper arm, and they will administer the second dose 28 calendar days after the first.

How effective is the Moderna vaccine?

Important note: Efficacy describes how something performs under ideal and controlled circumstances (e.g., clinical trials). Effectiveness describes the performance of something in “real world” situations.

According to WHO, the Moderna COVID-19 vaccine’s clinical trial results show that it has an efficacy of approximately 92 percent in protecting against COVID-19, starting 14 days after the first dose.

In clinical trials, approximately 15,400 individuals 18 years of age and older have received at least 1 dose of the Moderna vaccine. The vaccine also appeared to have high efficacy among people of diverse age, sex, race, and ethnicity categories and persons with underlying medical conditions.

Although few people in the clinical trials were admitted to the hospital, this happened less often in the people who got the Moderna vaccine compared to people who got the placebo (saline solution).

Another study currently undergoing peer review investigated the real-world effectiveness of the Moderna and Pfizer vaccines. The findings suggest that getting both doses of either COVID-19 vaccine was 88.7% effective in preventing infection.

Can children receive the Moderna vaccine?

The World Health Organisation’s Strategic Advisory Group of Experts (SAGE) recommends the Moderna vaccine for people aged 18 years and older.

Is the Moderna vaccine safe for people with pre-existing medical conditions?

According to WHO, the vaccine is safe and effective for:

• People with known medical conditions associated with increased risk of severe disease, such as hypertension, diabetes, asthma, pulmonary, liver or kidney disease, as well as chronic infections that are stable and controlled.
  
  
• Immunocompromised persons such as those with autoimmune disease, HIV, cancer patients currently undergoing immunosuppressive therapy, transplant patients, those undergoing steroid treatment, and patients who are bedridden or with a poor prognosis.
  
  
• Persons with comorbidities such as:
  

• Chronic respiratory disease and infection such as asthma and respiratory allergies 
• Chronic obstructive pulmonary disease, interstitial lung diseases, cystic fibrosis, or pulmonary hypertension, pulmonary tuberculosis, chronic bronchitis, histoplasmosis, or bronchiectasis
• Cardiovascular disease such as hypertension coronary heart diseases, cardiomyopathies, peripheral artery disease, aortic diseases, rheumatic heart disease, or congenital heart disease
• Chronic kidney disease 
• Cerebrovascular diseases such as stroke and transient ischemic attack 
• Cancer of malignancy 
• Diabetes mellitus type 1 and type 2 
• Obesity 
• Neurological diseases such as dementia, Alzheimer’s disease, Parkinson’s disease, epilepsy and seizures, bell’s palsy, Guillen-barre syndrome, or acute spinal cord injury 
• Chronic liver disease such as hepatitis cirrhosis, non-alcoholic fatty liver disease
• Immunodeficiency state such as genetic immunodeficiencies, secondary or acquired immunodeficiencies (i.e. prolonged use of corticosteroids) 
• HIV infection 
• Solid organ or blood transplant patients 
• Other diseases such as sickle cell disease, thalassemia, or down syndrome 
  

If you are uncertain or would like to gain further clarity on your specific condition, please consult with your doctor.

For more information, click here.  
https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html 

Can pregnant and breastfeeding women get vaccinated?

• Breastfeeding women who are part of a group recommended for vaccination (e.g. health workers); discontinuing breastfeeding after vaccination is currently not recommended.
  
  
• Pregnant women at high risk of exposure to SARS-CoV-2 (e.g., health workers) or have comorbidities which add to their risk of severe disease, may be vaccinated in consultation with their health care provider. 
  

Can people who had and have recovered from COVID-19 be vaccinated?

Individuals who recently recovered from COVID-19 may be vaccinated immediately after recovery or completion of treatment for their first or second dose. However, individuals may wish to defer their own COVID-19 vaccination for up to six months from the time of SARS-CoV-2 infection.

Who should NOT get vaccinated?

• Currently, the vaccine should not be administered to persons younger than 18 years of age due to the pending results of further studies.
  
  
• You should not get the vaccine if you have had a severe allergic reaction (anaphylaxis) or an immediate allergic reaction to any ingredient in an mRNA COVID-19 vaccine. View the list of ingredients here.
  
  
• In the case that you had an allergic reaction (mild to severe) after getting the first dose of the vaccine, you should not get a second dose of an mRNA COVID-19 vaccines (Moderna or Pfizer).
  
  
• WHO recommends that older persons with an anticipated life expectancy of less than 3 months should be individually assessed.
   
• Individuals experiencing a blood pressure (BP) of 180/120 or higher with signs and symptoms of organ damage determined during the pre-vaccination screening process cannot be vaccinated. 
  

Medical clearance is not needed except for immunocompromised individuals.

Is medical clearance required?

What are the possible side effects?

You may experience one or more the following upon taking the shot.

Arm Area

• Pain
• Redness
• Swelling
  
  

Rest of the Body

• Tiredness
• Headache 
• Muscle pain 
• Chills 
• Fever 
• Nausea 
  

These side effects can occur within a day or two of getting the vaccine, but they should disappear in a few days.

What should I disclose before getting the Moderna vaccine?

You should share all of your medical conditions, including if you:

• have any allergies 
• have a fever 
• have a bleeding disorder or are on a blood thinner 
• are immunocompromised or are on a medicine that affects your immune system 
• are pregnant or plan to become pregnant 
• are breastfeeding 
• have received another COVID-19 vaccine already
  

If I got vaccinated with Moderna for my first dose, can I get vaccinated with a different brand of vaccine for my second dose?

No, you shouldn't. A series started with the Moderna vaccine should only be completed with the same product.

What are the benefits of the Moderna COVID-19 vaccine?

In an ongoing clinical trial, the Moderna COVID-19 vaccine is proven to prevent COVID-19 following 2 doses given 1 month apart. The duration of protection against COVID-19 is currently unknown.

Does the vaccine work against new variants?

Based on the latest evidence collected by WHO, the new variants of SARS-CoV-2, including the B.1.1.7 (UK variant) and the 501Y.V2 (South African variant), do not alter the effectiveness of the Moderna mRNA vaccine.

Will the vaccine give me COVID-19?

No. The Moderna COVID-19 vaccine does not contain SARS-CoV-2 and cannot give you COVID-19.

Will the vaccine affect or change my DNA?

No. The Moderna COVID-19 vaccine does not affect or interact with a person’s DNA in any way.

How does the vaccine work?

The Moderna COVID-19 vaccine is an encapsulated mRNA vaccine. This type of vaccine gives instructions to our cells for the creation of a harmless “spike protein” that will develop the body’s immune response against COVID-19.

How is the Moderna vaccine given?

Only authorised healthcare professionals will administer the vaccine in two separate doses.

They will give the vaccine as an injection into the upper arm, and they will administer the second dose 28 calendar days after the first.

How effective is the Moderna vaccine?

Important note: Efficacy describes how something performs under ideal and controlled circumstances (e.g., clinical trials). Effectiveness describes the performance of something in “real world” situations.

According to WHO, the Moderna COVID-19 vaccine’s clinical trial results show that it has an efficacy of approximately 92 percent in protecting against COVID-19, starting 14 days after the first dose.

In clinical trials, approximately 15,400 individuals 18 years of age and older have received at least 1 dose of the Moderna vaccine. The vaccine also appeared to have high efficacy among people of diverse age, sex, race, and ethnicity categories and persons with underlying medical conditions.

Although few people in the clinical trials were admitted to the hospital, this happened less often in the people who got the Moderna vaccine compared to people who got the placebo (saline solution).

Another study currently undergoing peer review investigated the real-world effectiveness of the Moderna and Pfizer vaccines. The findings suggest that getting both doses of either COVID-19 vaccine was 88.7% effective in preventing infection. 

Can children receive the Moderna vaccine?

The World Health Organisation’s Strategic Advisory Group of Experts (SAGE) recommends the Moderna vaccine for people aged 18 years and older.

Is the Moderna vaccine safe for people with pre-existing medical conditions?

According to WHO, the vaccine is safe and effective for:

• People with known medical conditions associated with increased risk of severe disease, such as hypertension, diabetes, asthma, pulmonary, liver or kidney disease, as well as chronic infections that are stable and controlled.
  
  
• Immunocompromised persons such as those with autoimmune disease, HIV, cancer patients currently undergoing immunosuppressive therapy, transplant patients, those undergoing steroid treatment, and patients who are bedridden or with a poor prognosis.
  
  
• Persons with comorbidities such as:
  

• Chronic respiratory disease and infection such as asthma and respiratory allergies 
• Chronic obstructive pulmonary disease, interstitial lung diseases, cystic fibrosis, or pulmonary hypertension, pulmonary tuberculosis, chronic bronchitis, histoplasmosis, or bronchiectasis
• Cardiovascular disease such as hypertension coronary heart diseases, cardiomyopathies, peripheral artery disease, aortic diseases, rheumatic heart disease, or congenital heart disease
• Chronic kidney disease 
• Cerebrovascular diseases such as stroke and transient ischemic attack 
• Cancer of malignancy 
• Diabetes mellitus type 1 and type 2 
• Obesity 
• Neurological diseases such as dementia, Alzheimer’s disease, Parkinson’s disease, epilepsy and seizures, bell’s palsy, Guillen-barre syndrome, or acute spinal cord injury 
• Chronic liver disease such as hepatitis cirrhosis, non-alcoholic fatty liver disease
• Immunodeficiency state such as genetic immunodeficiencies, secondary or acquired immunodeficiencies (i.e. prolonged use of corticosteroids) 
• HIV infection 
• Solid organ or blood transplant patients 
• Other diseases such as sickle cell disease, thalassemia, or down syndrome 
  

If you are uncertain or would like to gain further clarity on your specific condition, please consult with your doctor.

For more information, 
click here.  
https://www.cdc.gov/
coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html  

Can pregnant and breastfeeding women get vaccinated?

• Breastfeeding women who are part of a group recommended for vaccination (e.g. health workers); discontinuing breastfeeding after vaccination is currently not recommended.
  
  
• Pregnant women at high risk of exposure to SARS-CoV-2 (e.g., health workers) or have comorbidities which add to their risk of severe disease, may be vaccinated in consultation with their health care provider. 
  

Can people who had and have recovered from COVID-19 be vaccinated?

Individuals who recently recovered from COVID-19 may be vaccinated immediately after recovery or completion of treatment for their first or second dose. However, individuals may wish to defer their own COVID-19 vaccination for up to six months from the time of SARS-CoV-2 infection.

Who should NOT get vaccinated?

• Currently, the vaccine should not be administered to persons younger than 18 years of age due to the pending results of further studies.
  
  
• You should not get the vaccine if you have had a severe allergic reaction (anaphylaxis) or an immediate allergic reaction to any ingredient in an mRNA COVID-19 vaccine. View the list of ingredients here.
  
  
• In the case that you had an allergic reaction (mild to severe) after getting the first dose of the vaccine, you should not get a second dose of an mRNA COVID-19 vaccines (Moderna or Pfizer).
  
  
• WHO recommends that older persons with an anticipated life expectancy of less than 3 months should be individually assessed.
   
• Individuals experiencing a blood pressure (BP) of 180/120 or higher with signs and symptoms of organ damage determined during the pre-vaccination screening process cannot be vaccinated. 
  

Is medical clearance required?

Medical clearance is not needed except for immunocompromised individuals.

What are the possible side effects?

You may experience one or more the following upon taking the shot.

Arm Area 

• Pain 
• Redness 
• Swelling

Rest of the Body

• Tiredness
• Headache 
• Muscle pain 
• Chills 
• Fever 
• Nausea

These side effects can occur within a day or two of getting the vaccine, but they should disappear in a few days.

What should I disclose before getting the Moderna vaccine?